Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G Laing^#¹, Anna Lorenc^#¹, Irene Del Molino Del Barrio^#^{1

2}, Abhishek Das^#^{1

3}, Matthew Fish^#^{1

4}, Leticia Monin^#⁵, Miguel Muñoz-Ruiz^#⁵, Duncan R McKenzie^#⁵, Thomas S Hayday^#¹, Isaac Francos-Quijorna^#⁶, Shraddha Kamdar^#¹, Magdalene Joseph¹, Daniel Davies^{1

7}, Richard Davis¹, Aislinn Jennings^{1

4}, Iva Zlatareva¹, Pierre Vantourout¹, Yin Wu^{1

2

5}, Vasiliki Sofra¹, Florencia Cano⁵, Maria Greco⁵, Efstathios Theodoridis¹, Joshua Freedman¹, Sarah Gee¹, Julie Nuo En Chan⁸, Sarah Ryan⁹, Eva Bugallo-Blanco⁸, Pärt Peterson¹⁰, Kai Kisand¹⁰, Liis Haljasmägi¹⁰, Loubna Chadli¹¹, Philippe Moingeon¹¹, Lauren Martinez¹², Blair Merrick¹³, Karen Bisnauthsing¹³, Kate Brooks¹², Mohammad A A Ibrahim¹⁴, Jeremy Mason¹⁵, Federico Lopez Gomez¹⁵, Kola Babalola¹⁵, Sultan Abdul-Jawad⁸, John Cason^{16

17}, Christine Mant^{16

17}, Jeffrey Seow¹⁶, Carl Graham¹⁶, Katie J Doores¹⁶, Francesca Di Rosa¹⁸, Jonathan Edgeworth¹³, Manu Shankar-Hari^{19

20}, Adrian C Hayday^{21

22}

Affiliations

¹ Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
² UCL Cancer Institute, University College London, London, UK.
³ London School of Hygiene & Tropical Medicine, London, UK.
⁴ Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁵ The Francis Crick Institute, London, UK.
⁶ Regeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King's College London, London, UK.
⁷ Department of Plastic and Reconstructive Surgery, Royal Free NHS Foundation Trust, London, UK.
⁸ Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
⁹ Department of Inflammation Biology, King's College London, London, UK.
¹⁰ Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
¹¹ Center for Therapeutic Innovation in Immuno-inflammation, Servier, France.
¹² Infectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹³ Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹⁴ Immunological Medicine, Kings College Hospital NHS Foundation Trust, London, UK.
¹⁵ The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.
¹⁶ Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
¹⁷ Infectious Diseases Biobank, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
¹⁸ Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, Italy.
¹⁹ Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. manu.shankar-hari@kcl.ac.uk.
²⁰ Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK. manu.shankar-hari@kcl.ac.uk.
²¹ Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.
²² The Francis Crick Institute, London, UK. adrian.hayday@kcl.ac.uk.

^# Contributed equally.

PMID: 32908251
PMCID: PMC7479399
DOI: 10.1038/s41591-020-1079-x

Published Erratum

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G Laing et al. Nat Med. 2020 Oct.

. 2020 Oct;26(10):1663.

doi: 10.1038/s41591-020-1079-x.

Authors

Affiliations

¹ Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
² UCL Cancer Institute, University College London, London, UK.
³ London School of Hygiene & Tropical Medicine, London, UK.
⁴ Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁵ The Francis Crick Institute, London, UK.
⁶ Regeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King's College London, London, UK.
⁷ Department of Plastic and Reconstructive Surgery, Royal Free NHS Foundation Trust, London, UK.
⁸ Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
⁹ Department of Inflammation Biology, King's College London, London, UK.
¹⁰ Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
¹¹ Center for Therapeutic Innovation in Immuno-inflammation, Servier, France.
¹² Infectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹³ Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
¹⁴ Immunological Medicine, Kings College Hospital NHS Foundation Trust, London, UK.
¹⁵ The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.
¹⁶ Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
¹⁷ Infectious Diseases Biobank, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
¹⁸ Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, Italy.
¹⁹ Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. manu.shankar-hari@kcl.ac.uk.
²⁰ Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK. manu.shankar-hari@kcl.ac.uk.
²¹ Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.
²² The Francis Crick Institute, London, UK. adrian.hayday@kcl.ac.uk.

^# Contributed equally.

PMID: 32908251
PMCID: PMC7479399
DOI: 10.1038/s41591-020-1079-x

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

A dynamic COVID-19 immune signature includes associations with poor prognosis.
Laing AG, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L, Muñoz-Ruiz M, McKenzie DR, Hayday TS, Francos-Quijorna I, Kamdar S, Joseph M, Davies D, Davis R, Jennings A, Zlatareva I, Vantourout P, Wu Y, Sofra V, Cano F, Greco M, Theodoridis E, Freedman JD, Gee S, Chan JNE, Ryan S, Bugallo-Blanco E, Peterson P, Kisand K, Haljasmägi L, Chadli L, Moingeon P, Martinez L, Merrick B, Bisnauthsing K, Brooks K, Ibrahim MAA, Mason J, Lopez Gomez F, Babalola K, Abdul-Jawad S, Cason J, Mant C, Seow J, Graham C, Doores KJ, Di Rosa F, Edgeworth J, Shankar-Hari M, Hayday AC. Laing AG, et al. Nat Med. 2020 Oct;26(10):1623-1635. doi: 10.1038/s41591-020-1038-6. Epub 2020 Aug 17. Nat Med. 2020. PMID: 32807934

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Affiliations

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources